No Clinically Relevant Changes in Vitamin D with PA21
Researchers compared the novel iron-based phosphate binder with sevelamer.
NKF 2014 Spring Clinical Meeting
Anemia Management Changing in Peritoneal Dialysis Patients
Study reveals a decline in the use of erythropoiesis-stimulating agents and an increase in the use of iron.
Acute Rejection Linked to Ketoconazole
When administered concomitantly with tacrolimus in kidney transplant patients, it hiked the risk of acute rejection by more than 2-fold.
High Phosphorus Ups Anemia Risk in the Non-CKD Population
Each 0.5 mg/dL increment in phosphorus was associated with a 7% increased risk of anemia.
Inappropriate ESA Use Reduced by Pharmacy Protocol
Ordering process cut the number of epoetin alfa doses by 71% and medication costs by 69%.
Transplant Outcomes Better in IgA Nephropathy Patients
Their unadjusted 5-year death-censored graft survival and patient survival rates are higher compared with other recipients.
Team-Focused Approach Improves Phosphorus Control
In a study, nurses and technicians educated groups of hemodialysis patients about phosphate binders.
Diabetic Foot Ulcers Raise ESRD Patient Costs
Study reveals an association with greater use of ESAs and higher inpatient and outpatient costs.
Multi-Prong Approach Has Little Effect on Phosphorus Control
Researchers tested an intervention that included an educational fair, phosphorus group social, and staff education on phosphate binders.
Safety Profiles of IV Iron Products Compared
In a head-to-head comparison, researchers observed a higher rate of adverse events with iron dextran than iron sucrose or ferric gluconate.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...